Global Neuromodulation Devices Market

Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast 2012 - 2018

  • Rep Id : TMRGL627
  • Published On : Oct 2012
  • No. of Pages : 125
  • Category : Healthcare

 

CHAPTER 1 PREFACE

1.1 REPORT DESCRIPTION

1.2 RESEARCH METHODOLOGY

 

CHAPTER 2 EXECUTIVE SUMMARY

 

CHAPTER 3 MARKET OVERVIEW

3.1 MARKET DYNAMICS

      3.1.1 DRIVERS

              3.1.1.1 Aging population inducing chronic diseases such as Parkinson’s and Alzheimer’s disorders

              3.1.1.2 Technological advancements

              3.1.1.3 Rising prevalence of chronic diseases and the presence of unmet medical needs

              3.1.1.4 Add on therapy nature of neuromodulation devices

              3.1.1.5 Increasing demand for minimally invasive surgeries

              3.1.1.6 Rising healthcare related consumer expenditure

              3.1.1.7 Rising instances of external funding to conduct clinical studies

              3.1.1.8 Increasing global prevalence of lifestyle induced illnesses such as depression and obesity

      3.1.2 IMPACT ANALYSIS OF DRIVERS

      3.1.3 RESTRAINTS

              3.1.3.1 Side effects and risks associated with the use of a neuromodulation  device

              3.1.3.2 FDA approvals and other government regulations

                         3.1.3.2.1 Affordable Healthcare for America Act, 2010

              3.1.3.3 Rapidly changing technologies

              3.1.3.4 Availability of alternate treatment procedures

     3.1.4 NEURMODULATION DEVICES MARKET RESTRAINTS IMPACT ANALYSIS

     3.1.5 OPPORTUNITIES

              3.1.5.1 Emerging economies in Asia, Latin America and Eastern European countries

              3.1.5.2 Medical device manufacture outsourcing

              3.1.5.3 Increasing clarity pursuant to the human nervous system

              3.1.5.4 Consolidation opportunities in the healthcare industry

      3.1.6 OPPORTUNITY IMPACT ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET

3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET

      3.2.1 BARGAINING POWER OF SUPPLIERS

      3.2.2 BARGAINING POWER OF BUYERS

      3.2.3 THREAT OF NEW ENTRANTS

      3.2.4 THREAT OF SUBSTITUTES

      3.2.5 COMPETITIVE RIVALRY

3.3 MARKET ATTRACTIVENESS ANALYSIS

      3.3.1 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

      3.3.2 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY

              3.3.2.1 Emerging and Future Market Trends by Technology

 

CHAPTER 4 NEUROMODULATION DEVICES MARKET BY TECHNOLOGY

4.1 OVERVIEW

       4.1.1 GLOBAL NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       4.1.2 GLOBAL NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018

4.2 SPINAL CORD STIMULATION DEVICES

       4.2.1 INTRODUCTION

       4.2.2 MARKET SIZE AND FORECAST

4.3 DEEP BRAIN STIMULATION DEVICES

       4.3.1 INTRODUCTION

       4.3.2 MARKET SIZE AND FORECAST

4.4 SACRAL NERVE STIMULATION DEVICES

       4.4.1 INTRODUCTION

       4.4.2 MARKET SIZE AND FORECAST

4.5 VAGUS NERVE STIMULATION DEVICES

       4.5.1 INTRODUCTION

       4.5.2 MARKET SIZE AND FORECAST

4.6 GASTRIC ELECTRIC STIMULATION DEVICES

       4.6.1 INTRODUCTION

       4.6.2 MARKET SIZE AND FORECAST

 

CHAPTER 5 NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

5.1 OVERVIEW

5.2 NORTH AMERICA

       5.2.1 MARKET OVERVIEW

       5.2.1 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       5.2.2 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

       5.2.3 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET

       5.2.4 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET

       5.2.5 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES MARKET

       5.2.6 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES MARKET

       5.2.7 NORTH AMERICA GASTRIC ELECTRIC STIMULATION DEVICES MARKET

5.3 EUROPE

       5.3.1 MARKET OVERVIEW

       5.3.2 EUROPE NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       5.3.3 EUROPE NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

       5.3.4 EUROPE SPINAL CORD STIMULATION DEVICES MARKET

       5.3.5 EUROPE DEEP BRAIN STIMULATION DEVICES MARKET

       5.3.6 EUROPE SACRAL NERVE STIMULATION DEVICES MARKET

       5.3.7 EUROPE VAGUS NERVE STIMULATION DEVICES MARKET

       5.3.8 EUROPE GASTRIC ELECTRIC STIMULATION DEVICES MARKET

5.4 ASIA PACIFIC

       5.4.1 MARKET OVERVIEW

       5.4.1 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       5.4.2 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018

       5.4.3 ASIA PACIFIC SPINAL CORD STIMULATION DEVICES MARKET

       5.4.4 ASIA PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET

       5.4.5 ASIA PACIFIC SACRAL NERVE STIMULATION DEVICES MARKET

       5.4.6 ASIA PACIFIC VAGUS NERVE STIMULATION DEVICES MARKET

       5.4.7 ASIA PACIFIC GASTRIC ELECTRIC STIMULATION DEVICES MARKET

5.5 REST OF THE WORLD

       5.5.1 MARKET OVERVIEW

       5.5.1 R.O.W NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       5.5.2 ROW NEUROMODULATION DEVICES MARKET BY VOLUME, NO. OF UNITS, 2011 – 2018

       5.5.3 R.O.W SPINAL CORD STIMULATION DEVICES MARKET

       5.5.4 R.O.W DEEP BRAIN STIMULATION DEVICES MARKET

       5.5.5 R.O.W SACRAL NERVE STIMULATION DEVICES MARKET

       5.5.6 R.O.W VAGUS NERVE STIMULATION DEVICES MARKET

       5.5.7 R.O.W GASTRIC ELECTRIC STIMULATION DEVICES MARKET

 

CHAPTER 6 COMPETITIVE LANDSCAPE

6.1 MARKET SHARE BY KEY PLAYERS

6.2 COMPETITIVE STRATEGIES BY KEY PLAYERS

       6.2.1 MARKET LEADERS

       6.2.2 NEW ENTRANTS

 

CHAPTER 7 RECOMMENDATIONS

7.1 MARKET STRATEGY FOR SUCCESS

7.2 BARRIERS TO BE CONSIDERED

 

CHAPTER 8 COMPANY PROFILES

8.1 KEY  PLAYERS

       8.1.1 MEDTRONIC

               8.1.1.1 Company Overview

               8.1.1.2 Business Strategies

               8.1.1.4 Financial Overview

               8.1.1.5 Product Portfolio

               8.1.1.6 Recent Developments

      8.1.2 ST. JUDE MEDICAL

               8.1.2.1 Company Overview

               8.1.2.2 Business Strategies

               8.1.2.4 Financial Overview

               8.1.2.5 Product Portfolio

               8.1.2.6 Recent Developments

      8.1.3 BOSTON SCIENTIFIC

               8.1.3.1 Company Overview

               8.1.3.2 Business Strategies

               8.1.3.4 Financial Overview

               8.1.3.5 Product Portfolio

               8.1.3.6 Recent Developments

      8.1.4 CYBERONICS

               8.1.4.1 Company Overview

               8.1.4.2 Business Strategies

               8.1.4.3 Financial Overview

               8.1.4.4 Product Portfolio

               8.1.4.5 Recent Developments

      8.1.5 NEVRO

               8.1.5.1 Company Overview

               8.1.5.2 Business Strategies

               8.1.5.3 Financial Overview

               8.1.5.4 Product Portfolio

               8.1.5.5 Recent Developments

8.2 NEW ENTRANTS

      8.2.1 NEURONETICS, INC.

               8.2.1.1 Company Overview

               8.2.1.2 Business Strategies

               8.2.1.3 Financial Overview

               8.2.1.4 Product Portfolio

               8.2.1.5 Recent Developments

      8.2.2 UROPLASTY

               8.2.2.1 Company Overview

               8.2.2.2 Business Strategies

               8.2.2.3 Financial Overview

               8.2.2.4 Product Portfolio

               8.2.2.5 Recent Developments

TABLE OF CONTENTS

 

TABLE 1 GLOBAL NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 – 2018 (USD MILLION)

TABLE 2 IMPACT ANALYSIS OF DRIVERS

TABLE 3 IMPACT ANALYSIS OF RESTRAINTS

TABLE 4 EMERGING AND FUTURE MARKET TRENDS BY TECHNOLOGY

TABLE 5 GLOBAL NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

TABLE 6 PRODUCTS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE SPINAL CORD STIMULATION DEVICES MARKET

TABLE 7 GLOBAL SPINAL CORD STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 8 GLOBAL SPINAL CORD STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 9 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE DEEP BRAIN STIMULATION DEVICES MARKET

TABLE 10 GLOBAL DEEP BRAIN STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 11 GLOBAL DEEP BRAIN STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 12 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE SACRAL NERVE STIMULATION DEVICES MARKET

TABLE 13 GLOBAL SACRAL NERVE STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 14 GLOBAL SACRAL NERVE STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 15 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE VAGUS NERVE STIMULATION DEVICES MARKET

TABLE 16 GLOBAL VAGUS NERVE STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 17 GLOBAL VAGUS NERVE STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 18 GLOBAL GASTRIC ELCTRIC STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 19 GLOBAL GASTRIC ELECTRIC STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 20 NORTH AMERICA NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

TABLE 21 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

TABLE 22 EUROPE NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

TABLE 23 EUROPE NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

TABLE 24 ASIA PACIFIC NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

TABLE 25 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

TABLE 26 R.O.W NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

TABLE 27 R.O.W NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

LIST OF FIGURES

 

FIG. 1 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

FIG. 2 HEALTHCARE RELATED CONSUMER EXPENDITURE IN JAPAN, U.S., GERMANY AND CANADA, 2008 TO 2010 (USD  MILLION)

FIG. 3 HEALTHCARE RELATED CONSUMER EXPENDITURE IN BRAZIL, INDIA AND CHINA, 2008 TO 2010 (USD  MILLION)

FIG. 4 OPPORTUNITY IMPACT ANALYSIS FOR THE NEUROMODULATION DEVICES  MARKET

FIG. 5 PORTER’S FIVE FORCES ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET

FIG. 6 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

FIG. 7 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY

FIG. 8 COMPARITIVE ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 9 GLOBAL NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 10 GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 11 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 12 GLOBAL SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 13 GLOBAL VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 14 GLOBAL GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 15 COMPARATIVE ANALYSIS OF THE NEUROMODULATION DEVICES MARKET BY GEOGRAPHY, 2011 & 2018 (%)

FIG. 16 COMPARATIVE ANALYSIS OF THE NORTH AMERICAN NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 17 NORTH AMERICA NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 18 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 19 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 20 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 21 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 22 NORTH AMERICA GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 23 COMPARATIVE ANALYSIS OF THE EUROPEAN NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 24 EUROPE NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 25 EUROPE SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 26 EUROPE DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 27 EUROPE SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 28 EUROPE VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 29 EUROPE GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 30 COMPARATIVE ANALYSIS OF THE ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 31 ASIA PACIFIC NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 32 ASIA PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 33 ASIA PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 34 ASIA PACIFIC SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 35 ASIA PACIFIC VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 36 ASIA PACIFIC GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 37 COMPARITIVE ANALYSIS OF THE R.O.W NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 38 R.O.W NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 39 R.O.W SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 40 R.O.W DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 41 R.O.W SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 42 R.O.W VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 43 R.O.W GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 44 MARKET SHARE BY KEY PLAYERS, 2011 (%)

FIG. 45 SWOT ANALYSIS OF MEDTRONIC

FIG. 46 ANNUAL REVENUE (USD MILLION) OF MEDTRONIC, 2008 - 2011

FIG. 47 SWOT ANALYSIS OF ST. JUDE MEDICAL

FIG. 48 ANNUAL REVENUE (USD MILLION) OF ST. JUDE MEDICAL, 2008 - 2011

FIG. 49 SWOT ANALYSIS OF BOSTON SCIENTIFIC GROUP

FIG. 50 ANNUAL REVENUE (USD MILLION) OF BOSTON SCIENTIFIC GROUP, 2008 - 2011

FIG. 51 ANNUAL REVENUE (USD MILLION) OF CYBERONICS, 2008 - 2011

FIG. 52 ANNUAL REVENUE (USD MILLION) OF UROPLASTY, 2008 - 2011